

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hodgkin disease | D006689 | — | C81 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
| Meningeal neoplasms | D008577 | EFO_0003851 | C70 | — | 1 | — | — | — | 1 |
| Meningeal carcinomatosis | D055756 | EFO_1001012 | — | — | 1 | — | — | — | 1 |
| Drug common name | Cilmostim |
| INN | cilmostim |
| Description | Cilmostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108239 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | EWL6971ETP (ChemIDplus, GSRS) |

